我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

氨氯地平和依那普利联合治疗高血压病左心室舒张功能不全的疗效

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2009年第5期
页码:
683-685
栏目:
临床研究
出版日期:
2009-07-14

文章信息/Info

Title:
Combined administration of levamlodipine and enalapril in treatment of hypertensive patients with left ventricular diastolic dysfunction
作者:
张磊黎瑶戴祖荣姜轶周夏飞黄秀萍
成都医学院第一附属医院心内科,四川 成都 610500
Author(s):
ZHANG Lei LI Yao DAI Zu-rong JIANG Yi ZHOU Xia-fei HUANG Xiu-ping
Department of Cardiology, First Affiliated Hospital, Chengdu Medical College, Chengdu 610500, Sichuan, China
关键词:
高血压原发性舒张功能不全钙离子拮抗剂血管紧张素转换酶抑制剂
Keywords:
hypertension diastolic dysfunction calcium channel blocker angiotensin-converting enzyme inhibitor
分类号:
R972.4
DOI:
-
文献标识码:
A
摘要:
目的: 研究高血压病患者左室舒张功能不全治疗的最佳方案。方法: 将60例门诊高血压病患者随机分为3组:氨氯地平组给予苯磺酸左旋氨氯地平5 mg每晚1次;依那普利组给予马来酸依那普利10 mg每日2次;联合用药组给予苯磺酸左旋氨氯地平2.5 mg每晚1次+马来酸依那普利5 mg每日2次。对比治疗前和6个月后随访时的左室射血分数(LVEF)、心电机械图S2至E峰时间(IVRT)、二尖瓣血流峰值速度E/A,并对比各组中不良反应的发生率。结果: 3组内治疗前后LVEF无显著性差异;IVRT、E/A改善具有显著性。3组间治疗后结果比较LVEF、IVRT均无统计学差异,联合用药组E/A较单独用药组具有统计学差异(均P<0.05)。结论: 对伴有左心室舒张功能不全的高血压病患者,氨氯地平和依那普利对舒张功能的指标均有改善;而氨氯地平和依那普利小剂量联合使用,对舒张功能的指标E/A有更显著地改善,且副作用发生率较低。
Abstract:
AIM: To explore a better therapy program for hypertensive patients with left ventricular diastolic dysfunction. METHODS: Sixty hypertensive out-patients were randomly divided into three groups: Group 1 treated with levamlodipine besilate (5 mg) nightly, Group 2 treated with enalapril maleate (10 mg) twice daily, and Group 3 treated with levamlodipine besilate (2.5 mg) nightly plus enalapril maleate (5 mg) twice daily. LVEF, IVRT, E/A, and side effects were recorded before treatment and 6 months after treatment. RESULTS: LVEF of the three groups before and after treatment showed no significant differences. IVRT and E/A improved significantly (P<0.05). After treatment, LVEF and IVRT showed no significant difference among the three groups. Compared with that in Group 1 and Group 2, Group 3 E/A was significantly different (P<0.05). CONCLUSION: In the treatment of hypertensive patients with diastolic dysfunction, levamlodipine besilate and enalapril maleate improve the indicator of diastolic function. The combination of low-dose levamlodipine besilate and enalapril maleate significantly improves the E/A with few side effects.

参考文献/References

[1] European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure[J]. Eur Heart J, 1998, 19(7):990-1003.

[2] Marsozs SP, Griffin BP, Topal EJ. 心血管内科手册[M]. 陈灏珠,主译. 北京: 人民卫生出版社, 2001:148-149.

[3] Ommen SR. Echocardiographic assessment of diastolic function[J]. Curr Opin Cardiol, 2001, 16(4):240-245.

[4] 臧益民,朱妙章,袁丽君,等. 心脏功能无创伤检测的研究进展[J]. 心脏杂志, 2005, 17(3):292-306.

[5] Lenihan DJ, Gerson MC, Hoit BD, et al. Mechanisms, diagnosis, and treatment of diastolic heart failure[J]. Am Heart J, 1995, 130(1):153-166.

[6] Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEPCHF)study[J]. Eur Heart J, 2006, 27(19):2338-2345.

[7] 中华医学会心血管病分会,中华心血管病杂志编辑委员会.血管紧张素转换酶抑制剂在心血管病中应用中国专家共识[J]. 中华心血管病杂志, 2007, 35(2):97-106.

[8] Daholf B, Sever P, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm(ASCOT-BPLA): a multicentre randomized controlled trial[J]. Lancet, 2005, 366(9489):895-906.

[9] Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system[J]. Circulation, 1991, 83(6):1849-1865.

备注/Memo

备注/Memo:
收稿日期:2008-12-9.作者简介:张磊,副主任医师Email:zhl.037@163.com
更新日期/Last Update: 2009-07-22